(Q40096082)

17 September 2017

Prostate-specific antigen density: a better index of obesity-related PSA decrease in ostensibly healthy Korean men with a PSA <3.0 ng/mL. (English)

1 reference

17 September 2017

0 references

4

Yun Seob Song

1 reference

17 September 2017

Jae Heon Kim

1

1 reference

17 September 2017

Seung Whan Doo

series ordinal

2

1 reference

17 September 2017

Won Jae Yang

series ordinal

3

1 reference

17 September 2017

Soon-Sun Kwon

series ordinal

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

7 March 2013

1 reference

17 September 2017

1 reference

17 September 2017

81

1 reference

17 September 2017

849-852

1 reference

17 September 2017

4

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

17 September 2017

1 reference

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Central obesity as a risk factor for prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Metabolic factors associated with benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Criteria and classification of obesity in Japan and Asia-Oceania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

The association of body mass index and prostate-specific antigen in a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Effect of obesity and body fat distribution on sex hormones and insulin in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Obesity and benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Obesity and prostate enlargement in men with localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2012.11.058

10.1016/J.UROLOGY.2012.11.058

7 January 2021

Identifiers

DOI

1 reference

17 September 2017

1 reference